Skip to main content
Smart Investors Daily
SQ

NASDAQ · SQL

SeqLL Inc.

Healthcare · Medical - Diagnostics & Research

$6.60

Down-$0.16 (-2.38%)

Updated Aug 25, 2026, 11:21 AM

SID Score

Composite research score

Smart Money

Institutional and insider signal

Market cap
2.51M
P/E ratio
-0.02
Dividend yield
0.00%
52-week range
— – —
Volume
19.32K
Avg. volume
82.89K

Price performance

SQL price history

1M range · 0 trading sessions · Daily adjusted prices

SQL does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest SQL news

The latest Smart Investors Daily articles mentioning SQL.

SQL research

Overview

Company profile and research snapshot.

Company profile

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
SQL recent ratings
DateFirmRatingTarget
Feb 9, 2022Maxim GroupBuy
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Sep 18, 2023

S&P 500 Moves Higher; Avinger Shares Jump

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 50 points on Monday. The Dow traded up 0.15% to 34,670.16 while the NASDAQ rose 0.15% to 13,729.44. The S&P 500 also rose, gaining, 0.19% to 4,458.71. Check This Out: Plus Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying   Leading and Lagging Sectors Energy shares rose by 0.7% on Monday. In trading on Monday, consumer discretionary shares fell by 0.7%.   Top Headline The NAHB/Wells Fargo Housing Market Index fell for a second month to a reading of 45 in September, recording the weakest level in five months, compared to 50 in August and versus market estimates of 50.   Equities Trading UP Nikola Corporation (NASDAQ: NKLA) shares shot up 33% to $1.58 after the company announced the appointment of a new chief operating officer. Shares of Avinger, Inc. (NASDAQ: AVGR) got a boost, shooting 67% to $6.91 amid the company announcing the commercial launch of its Tigereye ...

Benzinga · Sep 18, 2023

Crude Oil Rises Over 1%; US Housing Market Index Falls In September

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 70 points on Monday. The Dow traded up 0.21% to 34,690.63 while the NASDAQ rose 0.21% to 13,736.52. The S&P 500 also rose, gaining, 0.26% to 4,461.92. Check This Out: Plus Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying   Leading and Lagging Sectors Energy shares rose by 0.9% on Monday. In trading on Monday, consumer discretionary shares fell by 0.9%.   Top Headline The NAHB/Wells Fargo Housing Market Index fell for a second month to a reading of 45 in September, recording the weakest level in five months, compared to 50 in August and versus market estimates of 50.   Equities Trading UP Nikola Corporation (NASDAQ: NKLA) shares shot up 17% to $1.3899 after the company announced the appointment of a new chief operating officer. Shares of Avinger, Inc. (NASDAQ: AVGR) got a boost, shooting 76% to $7.25 amid the company announcing the commercial launch of its Tigereye ST image-guided CTO ...

GlobeNewswire Inc. · Feb 7, 2023

SeqLL Announces CRADA with the FBI

BILLERICA, Mass., Feb. 07, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL”, NASDAQ: SQL), a technology company providing life sciences instrumentation and research services, today announced the establishment of a two-year Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Justice’s Federal Bureau of Investigation (FBI). Under this CRADA, SeqLL and the FBI Laboratory Division (FBI LD) will seek to evaluate and determine the forensic capabilities of direct RNA sequencing using SeqLL’s True Single Molecule Sequencing (tSMS®) platform.

GlobeNewswire Inc. · Dec 13, 2022

Brian Paras joins SeqLL as Chief Business Officer

BILLERICA, Mass., Dec. 13, 2022 (GLOBE NEWSWIRE) --  SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL), a technology company providing life sciences instrumentation and research services, today announced that Brian Paras has joined the company as Chief Business Officer.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.